Keeping new antifungals as second-line agents only

Arch Oral Biol. 2011 Nov;56(11):1179-80. doi: 10.1016/j.archoralbio.2011.05.011. Epub 2011 Jun 17.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antifungal Agents / therapeutic use*
  • Aspergillosis / drug therapy
  • Candidiasis / drug therapy
  • Drug Resistance, Fungal*
  • Humans
  • Opportunistic Infections / drug therapy
  • Species Specificity

Substances

  • Antifungal Agents